Tissue and organ transplantation is a medical process that involves transplanting tissues or organs from a donor to a recipient. Transplantable tissues and organs include bones, heart, kidneys, liver, lungs, pancreas, skin, and intestines. Factors such as the growing prevalence of organ diseases including cardiovascular disease, kidney failure, liver disease, diabetes, which can potentially lead to organ failure. Advanced technologies in organ transplantation have facilitated life-saving organ transplantation procedures and minimized the chances of organ rejection.
The global Tissue And Organ Transplantation Market is estimated to be valued at Us$ 18.05 Billion In 2024 and is expected to exhibit a CAGR Of 7.9% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the global tissue and organ transplantation market is the growing adoption of regenerative medicine. Regenerative medicine uses healthy human tissues and organs to repair or replace tissues and organs damaged by injury or disease. It includes stem cell therapies, tissue engineering, organ regeneration, and a wide range of medical interventions. Regenerative medicine hold promises to potentially transform organ transplantation by addressing the shortage of donor organs through regenerating diseased organs or growing new organs in the laboratory. Several biotech companies are conducting research on bioengineering transplantable tissues and organs using 3D bioprinting techniques and stem cells to address the growing demand. This will help reduce the waiting list for organ transplants by increasing the availability of organs.
Threat of new entrants: Moderate. Regulations for organ transplantation are stringent, requiring significant investment and expertise to enter. However, growth opportunities exist.
Bargaining power of buyers: Moderate to High. Buyers have many options to choose from due to the presence of numerous organs and tissue banks.
Bargaining power of suppliers: Moderate. Suppliers of organs and tissues have some bargaining power due to limited availability of organs and tissues.
Threat of new substitutes: Low. There are very few substitutes for human organs and tissues available currently.
Competitive rivalry: High. The market is competitive with the presence of many private and public players focusing on new technologies and product innovations.
The Global Tissue And Organ Transplantation Market Demand is expected to witness high growth.
North America dominates the market currently due to rising prevalence of chronic diseases, technological advancements, and presence of leading players. Asia Pacific is expected to grow the fastest during the forecast period due to increasing awareness, healthcare spending, and availability of low-cost transplantation procedures.
Key players operating in the tissue and organ transplantation market are Probi AB, Chr. Hansen Holding A/S, Danone S.A., Yakult Honsha Co., Ltd., Nestle S.A., DowDuPont Inc., Kerry Group plc, BioGaia AB, Probiotics International Limited (Protexin), UAS Laboratories LLC. Probi AB is a global leader in probiotic bacteria. Chr. Hansen Holding A/S is a leading bioscience company providing natural ingredient solutions.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it